{
    "2020-09-03": [
        [
            {
                "time": "2020-09-15",
                "original_text": "Johnson & Johnson stock outperforms market despite losses on the day",
                "features": {
                    "keywords": [
                        "outperforms",
                        "market",
                        "losses"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "'Great for the manufacturers': How the law shields drug makers chasing a COVID vaccine",
                "features": {
                    "keywords": [
                        "manufacturers",
                        "law",
                        "shields",
                        "COVID",
                        "vaccine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "J&J's coronavirus vaccine candidate prevents severe disease in hamsters",
                "features": {
                    "keywords": [
                        "J&J",
                        "coronavirus",
                        "vaccine",
                        "candidate",
                        "prevents",
                        "severe",
                        "hamsters"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "We're still far away from a COVID-19 vaccine coming to market: Doctor",
                "features": {
                    "keywords": [
                        "far",
                        "away",
                        "COVID-19",
                        "vaccine",
                        "market",
                        "Doctor"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "J&J to Stop Development of Influenza Candidate Pimodivir",
                "features": {
                    "keywords": [
                        "J&J",
                        "Stop",
                        "Development",
                        "Influenza",
                        "Candidate",
                        "Pimodivir"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "EU hopeful first vaccine doses will come by end of year",
                "features": {
                    "keywords": [
                        "EU",
                        "hopeful",
                        "first",
                        "vaccine",
                        "doses",
                        "end",
                        "year"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "Robinhood's &quot;Free Stock&quot; Offer Isn't All It's Cracked Up to Be",
                "features": {
                    "keywords": [
                        "Robinhood",
                        "Free Stock",
                        "Offer",
                        "Isn't",
                        "Cracked",
                        "Up"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-15",
                "original_text": "Better Coronavirus Stock: AstraZeneca or Johnson & Johnson?",
                "features": {
                    "keywords": [
                        "Better",
                        "Coronavirus",
                        "Stock",
                        "AstraZeneca",
                        "Johnson",
                        "&",
                        "Johnson"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}